Moderna (MRNA) Stock Price
$23.4 0.5%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
4 -
Technical
3
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Moderna, AI stock picks, stock alerts and much more.
MRNA AI Stock Analysis
Financial Performance
The financial performance of Moderna shows mixed signals. The company's revenue has seen a significant increase by 669.7% from the previous quarter, but it is down by -34.1% year over year. Gross profit also shows a similar pattern with an impressive growth of 1477.6% quarter over quarter but a decline of -28.8% compared to the previous year. The operating income is in negative territory at -$70M, which indicates that the company's expenses are higher than its gross profit; this situation has worsened compared to last year with a decrease of -1266.7%. The EBITDA ratio stands at 0.04, which is relatively low and suggests that profitability might be an issue.
Stock Price
The stock price of Moderna has been on a downward trend recently; it decreased by -1% in the last month and significantly dropped by -59.3% year over year, currently trading at $41.41 per share, well below its 200-day moving average ($84.7). This could indicate bearish sentiment among investors or reflect broader market conditions affecting the sector or industry as a whole.
Alternative Data Signals
The alternative data signals also show some concerning trends for Moderna's stock performance outlook: web traffic is down by -26.7%, job openings have decreased by -20.6%, and there's been a decline in social media followership (Twitter down by -3%, Facebook down slightly by -0/4%). Employee morale seems neutral with only about half (47%) reporting positive business outlook.
Conclusion
In conclusion, based on these factors – financials showing mixed signals, a downtrend in stock price, and negative alternative data signals – the AI analysis for Moderna's stock performance is bearish.
Note: This AI Stock Analysis is based on data as of January 26. Our members can refresh and get access to an up-to-date AI stock analysis.
Sign up
Moderna (MRNA) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Moderna (MRNA), currently trading at $23.4, will... Sign up to access price prediction.
About MRNA
-
Moderna, Inc.
-
Symbol
MRNA
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
9.1B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$19.93 0.2% |
8 |
 |
Inovio Pharmaceuticals INO |
$2.31 3.2% |
2 |
 |
Anavex Life Sciences AVXL |
$9.1 2.9% |
5 |
 |
BridgeBio Pharma BBIO |
$50.93 0.6% |
6 |
 |
Crispr Therapeutics CRSP |
$56.92 1.2% |
5 |
News
MRNA Alternative Data
Web Traffic
Moderna receives an estimated 204489 monthly visitors to modernatx.com, which is up by 4.6% over the last month.
-
Web Traffic
204489
-
Change from Previous Month
4.6%
-
3 Month Change
7.3%
-
YoY Change
7.3%
Twitter Followers
Moderna has 144,362 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.1% over the last month.
-
Twitter Followers
144362
-
Daily Change
0%
-
1 Month Change
0.1%
-
3 Month Change
0.3%
-
YoY Change
0.3%
Facebook Engagement
Moderna has engaged 22 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
22
-
Daily Change
10%
-
1 Month Change
45%
-
3 Month Change
81.8%
-
YoY Change
81.8%
Youtube Subscribers
Moderna has 11,900 subscribers on its main Youtube channel.
-
Youtube Subscribers
11900
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Followers
705,716 are following Moderna on LinkedIn, up by 1.6% over the last month.
-
LinkedIn Followers
705716
-
Daily Change
0%
-
1 Month Change
1.6%
-
3 Month Change
4.9%
-
YoY Change
4.9%
Job Postings
Moderna currenly has an estimated 175 open job postings, up by 34.6% over the last month.
-
Job Postings
175
-
Daily Change
0%
-
1 Month Change
34.6%
-
3 Month Change
45.8%
-
YoY Change
45.8%
LinkedIn Employees
According to LinkedIn, Moderna has 6,612 employees, down by -2% over the last month.
-
LinkedIn Employees
6612
-
Daily Change
0%
-
1 Month Change
2%
-
3 Month Change
3.6%
-
YoY Change
3.6%
Reddit Mentions
Moderna has been mentioned an estimated 2 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
2
-
Daily Change
33.3%
-
1 Month Change
75%
-
3 Month Change
100%
Reddit Sentiment
The sentiment Score for Moderna is 32 out of 100, which represents a bearish sentiment.
-
Reddit Sentiment
31.8
-
Daily Change
36.4%
-
1 Month Change
36.4%
-
3 Month Change
38.1%
Business Outlook
According to employee reviews, the business outlook among employees at Moderna is 34 out of 100 (bearish), up by 3% over the last month.
-
Business Outlook
34
-
Change from Previous Month
3%
-
3 Month Change
8.1%
-
YoY Change
8.1%
News Mentions
Moderna was mentioned 14 times in the news yesterday.
-
News Mentions
14
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
MRNA Financials
MRNA Key Metrics
-
Total Revenue
$107M
-
Net Income
-$971M
-
Earnings per Share
-$2.52
-
Free cash flow
-$1.2B
-
EBITDA
-$924M
-
EBITDA Ratio
-8.63551
-
Total Assets
$12.7B
MRNA 2-year Revenue & Income
MRNA 2-year Free Cash Flow
MRNA Technicals
MRNA SMA
MRNA RSI
FAQ
What's the current price of Moderna (MRNA) Stock?
The price of an Moderna (MRNA) share is $23.4.
What's the market cap of Moderna?
The current market cap of Moderna is 9.1B.
What are some stocks similar to Moderna (MRNA) that investors often compare it to?
Moderna (MRNA) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Anavex Life Sciences, BridgeBio Pharma and Crispr Therapeutics.
What is the forecast for Moderna's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Moderna's stock price to be around $22.68 in 2026. Starting from the current price of $23.4, this represents a 3.1% change in price, indicating a neutral outlook for the stock.
How to buy Moderna (MRNA) Stock?
Moderna stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Moderna shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.